Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Sep;21(3):290-303.
doi: 10.1016/j.rbmo.2010.04.021. Epub 2010 Apr 27.

Prevention of intra-peritoneal adhesions in gynaecological surgery: theory and evidence

Affiliations
Review

Prevention of intra-peritoneal adhesions in gynaecological surgery: theory and evidence

G Pados et al. Reprod Biomed Online. 2010 Sep.

Abstract

Post-operative adhesions are a significant complication of all abdominal surgical procedures. The major strategies for adhesion prevention in gynaecological surgery are focused on the optimization of surgical technique and use of anti-adhesive agents, which fall into two main categories: pharmacological agents and barriers. Surgical technique that minimizes peritoneal trauma can reduce, but cannot prevent post-operative adhesion formation. Various local and systemic drugs that can alter the local inflammatory response, inhibit the coagulation cascade and promote fibrinolysis have been evaluated. Limited data support the administration of post-operative corticosteroids in addition to systemic intra-operative corticosteroids for the prevention of adhesions after gynaecological surgery. None of the remaining pharmacological agents have been found effective for the reduction of post-operative adhesions. Barriers are currently considered the most useful adjuncts, which may reduce adhesion formation. They act by separating the traumatized peritoneal surfaces during the healing period. The separation can be achieved by solid barriers or fluids. There is limited evidence from randomized clinical trials that support the beneficial effect of most of these barrier agents in the prevention of intra-peritoneal adhesions after gynaecological surgery. However, the evidence is not adequate for definite conclusions to be drawn and further research in this field is warranted.

PubMed Disclaimer

Comment in

  • Adhesion barrier market trends.
    Kim TH, Lee HH. Kim TH, et al. Reprod Biomed Online. 2015 May;30(5):558. doi: 10.1016/j.rbmo.2015.01.007. Epub 2015 Jan 27. Reprod Biomed Online. 2015. PMID: 25754226 No abstract available.
  • Response: adhesion barrier market trends.
    Pados G. Pados G. Reprod Biomed Online. 2015 May;30(5):559. doi: 10.1016/j.rbmo.2015.01.006. Epub 2015 Jan 27. Reprod Biomed Online. 2015. PMID: 25779019 No abstract available.

MeSH terms

LinkOut - more resources